Cargando…

High risk of renal dysfunction in patients with fulminant type 1 diabetes

AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Nobuyuki, Tsujimoto, Tetsuro, Chujo, Daisuke, Kajio, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754524/
https://www.ncbi.nlm.nih.gov/pubmed/28267278
http://dx.doi.org/10.1111/jdi.12652
_version_ 1783290434250866688
author Takahashi, Nobuyuki
Tsujimoto, Tetsuro
Chujo, Daisuke
Kajio, Hiroshi
author_facet Takahashi, Nobuyuki
Tsujimoto, Tetsuro
Chujo, Daisuke
Kajio, Hiroshi
author_sort Takahashi, Nobuyuki
collection PubMed
description AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes diagnosed during April 1993 to March 2016 at a national center in Japan. Glycated hemoglobin levels, incidence rates of renal dysfunction defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) and microalbuminuria were examined. RESULTS: In total, 115 patients with type 1 diabetes (10 with fulminant type 1 diabetes and 105 with acute‐onset type 1 diabetes) were included. The median glycated hemoglobin levels were significantly lower in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes 0, 3, 6 and 9 years after diabetes onset (6.5 vs 12.7%, 6.5 vs 7.9%, 6.7 vs 8.2%, 7.5 vs 8.5%, respectively). Kaplan–Meier analysis showed a significantly higher incidence rate of renal dysfunction in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes (hazard ratio 1.72, 95% confidence interval 1.01–2.97, P = 0.037). The incidence rate of microalbuminuria did not significantly differ between the groups (hazard ratio 0.97, 95% confidence interval 0.34–2.77, P = 0.95). Sensitivity analysis using age‐ and sex‐matched patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes yielded similar results. CONCLUSIONS: The risk of developing renal dysfunction is higher in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes, despite better glycemic control.
format Online
Article
Text
id pubmed-5754524
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57545242018-01-09 High risk of renal dysfunction in patients with fulminant type 1 diabetes Takahashi, Nobuyuki Tsujimoto, Tetsuro Chujo, Daisuke Kajio, Hiroshi J Diabetes Investig Articles AIMS/INTRODUCTION: To compare the incidence rate of renal dysfunction between patients with fulminant type 1 diabetes and those with acute‐onset type 1 diabetes. MATERIALS AND METHODS: The present retrospective cohort study included patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes diagnosed during April 1993 to March 2016 at a national center in Japan. Glycated hemoglobin levels, incidence rates of renal dysfunction defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) and microalbuminuria were examined. RESULTS: In total, 115 patients with type 1 diabetes (10 with fulminant type 1 diabetes and 105 with acute‐onset type 1 diabetes) were included. The median glycated hemoglobin levels were significantly lower in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes 0, 3, 6 and 9 years after diabetes onset (6.5 vs 12.7%, 6.5 vs 7.9%, 6.7 vs 8.2%, 7.5 vs 8.5%, respectively). Kaplan–Meier analysis showed a significantly higher incidence rate of renal dysfunction in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes (hazard ratio 1.72, 95% confidence interval 1.01–2.97, P = 0.037). The incidence rate of microalbuminuria did not significantly differ between the groups (hazard ratio 0.97, 95% confidence interval 0.34–2.77, P = 0.95). Sensitivity analysis using age‐ and sex‐matched patients with fulminant type 1 diabetes and acute‐onset type 1 diabetes yielded similar results. CONCLUSIONS: The risk of developing renal dysfunction is higher in patients with fulminant type 1 diabetes than in those with acute‐onset type 1 diabetes, despite better glycemic control. John Wiley and Sons Inc. 2017-04-13 2018-01 /pmc/articles/PMC5754524/ /pubmed/28267278 http://dx.doi.org/10.1111/jdi.12652 Text en © 2017 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Takahashi, Nobuyuki
Tsujimoto, Tetsuro
Chujo, Daisuke
Kajio, Hiroshi
High risk of renal dysfunction in patients with fulminant type 1 diabetes
title High risk of renal dysfunction in patients with fulminant type 1 diabetes
title_full High risk of renal dysfunction in patients with fulminant type 1 diabetes
title_fullStr High risk of renal dysfunction in patients with fulminant type 1 diabetes
title_full_unstemmed High risk of renal dysfunction in patients with fulminant type 1 diabetes
title_short High risk of renal dysfunction in patients with fulminant type 1 diabetes
title_sort high risk of renal dysfunction in patients with fulminant type 1 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754524/
https://www.ncbi.nlm.nih.gov/pubmed/28267278
http://dx.doi.org/10.1111/jdi.12652
work_keys_str_mv AT takahashinobuyuki highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes
AT tsujimototetsuro highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes
AT chujodaisuke highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes
AT kajiohiroshi highriskofrenaldysfunctioninpatientswithfulminanttype1diabetes